دورية أكاديمية

Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.

التفاصيل البيبلوغرافية
العنوان: Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.
المؤلفون: Sanchez-Macedo, N, Feng, J, Faubert, B, Chang, N, Elia, A, Rushing, E J, Tsuchihara, K, Bungard, D, Berger, S L, Jones, R G, Mak, T W, Zaugg, K
المصدر: Cell Death & Differentiation; Apr2013, Vol. 20 Issue 4, p659-668, 10p, 1 Color Photograph, 6 Graphs
مصطلحات موضوعية: P53 protein, GENE targeting, CARNITINE palmitoyltransferase, MITOCHONDRIAL enzymes, TUMOR growth, CELL metabolism, CARCINOGENESIS
مستخلص: Despite the prominent pro-apoptotic role of p53, this protein has also been shown to promote cell survival in response to metabolic stress. However, the specific mechanism by which p53 protects cells from metabolic stress-induced death is unknown. Earlier we reported that carnitine palmitoyltransferase 1C (CPT1C), a brain-specific member of a family of mitochondria-associated enzymes that have a central role in fatty acid metabolism promotes cell survival and tumor growth. Unlike other members of the CPT family, the subcellular localization of CPT1C and its cellular function remains elusive. Here, we report that CPT1C is a novel p53-target gene with a bona fide p53-responsive element within the first intron. CPT1C is upregulated in vitro and in vivo in a p53-dependent manner. Interestingly, expression of CPT1C is induced by metabolic stress factors such as hypoxia and glucose deprivation in a p53 and AMP activated kinase-dependent manner. Furthermore, in a murine tumor model, depletion of Cpt1c leads to delayed tumor development and a striking increase in survival. Taken together, our results indicate that p53 protects cells from metabolic stress via induction of CPT1C and that CPT1C may have a crucial role in carcinogenesis. CPT1C may therefore represent an exciting new therapeutic target for the treatment of hypoxic and otherwise treatment-resistant tumors. [ABSTRACT FROM AUTHOR]
Copyright of Cell Death & Differentiation is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:13509047
DOI:10.1038/cdd.2012.168